12 October 2023

  

Ranok Therapeutics to Present at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

 

 

- CSO Kevin Foley to highlight application of company’s innovative CHAMPâ technology to target ERK5, an emerging cancer target

 

 

Read More >

 

 

 

 

 

11 March 2024

  

Ranok Therapeutics Expands Clinical Testing of CHAMPâ BRD4 Protein Degrader RNK05047 to China

 

-- Study follows ongoing Phase 1 trial in U.S. and will enroll patients in China to evaluate the first protein degrader developed using Ranok’s innovative CHAMPâ technology

 

Read More >

 

 

 

 

 

4 April 2024

  

Ranok Therapeutics to Present at American Association for Cancer Research (AACR) Annual Meeting 2024

 

--Poster presentations to highlight application of company's innovative CHAMP® technology to important cancer targets including KRAS

 

Read More >

 

 

 

 

News

Events & Presentations
Press Releases & Media